Weeks 13-16: The Optimization Phase (1.7 mg) For those who tolerate the medication well and need additional weight loss support, the dose may increase to 1.7 mg weekly
This new class of medications is revolutionizing the management of diabetes and chronic obesity
Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists -Potential Game Changers in the Treatment of Glaucoma
Moreover, the long-term effects of therapeutic GIP receptor antagonism in humans are not fully elucidated and are thought to depend on the specific drug molecule, receptor functions, and the extent of GLP-1 receptor activation
Studies show that maintaining healthy glutathione levels may help reduce oxidative stress, improve liver enzyme balance, and support detoxification (NIH)